ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Genome Note
Revised

Whole genome sequencing data of Candida krusei, the pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia

[version 2; peer review: 2 approved]
PUBLISHED 29 Mar 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Genomics and Genetics gateway.

This article is included in the Pathogens gateway.

Abstract

Candida krusei is a Candida non-albicans species with a high prevalence, which causes candidaemia. Current treatment guidelines include fluconazole as a primary therapeutic option for the treatment of these infections; however, it is only a fungistatic against Candida spp., and both inherent and acquired resistance to fluconazole have been reported. C. krusei species is also reported as the only Candida sp. which has an intrinsic resistance factor to fluconazole. Therefore, in dealing with antifungal resistance, it is necessary to develop new antifungal agents that are efficient in the treatment of fungal infections, especially those caused by C. krusei. The purpose of this study was to investigate the genome of clinical C. krusei isolates and correlate the resistant phenotypes with mutations in resistance genes. A total of 16 samples of C. krusei from clinical samples from hospitals in Jakarta were used in the experiment. All colonies were extracted using the QIAamp DNA Mini Kit. The library was prepared using the Illumina DNA Prep Kit. The sequencing process was carried out on the Illumina MiSeq Platform using a 2x301 paired-end configuration. FASTQ raw files are available under the BioProject Accession Number PRJNA819536 and Sequence Read Archive Accession Numbers SRR18739949 and SRR18739964.

Keywords

Candida krusei, fluconazole, genomic profiling, resistance gene

Revised Amendments from Version 1

Revisions were made to the Introduction section within the manuscript.

To read any peer review reports and author responses for this article, follow the "read" links in the Open Peer Review table.

Introduction

Candida krusei (teleomorph Pichia kudriavzevii) is an opportunistic fungal pathogen.1 It is the fourth most common non-albicans Candida species (NAC) causing high prevalence and invasive candidiasis and candidemia.2,3 C. krusei is among unique species with natural resistance towards fluconazole, a commonly used antifungal for Candida infections.4 Therefore, in dealing with antifungal resistance, it is necessary to develop new antifungal agents that are efficient in the treatment of fungal infections, especially those caused by C. krusei One approach in examining the drug resistance of C. krusei is by sequencing the genome with potential roles in resistance. Here we report the whole genome sequencing data of Candida krusei from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia. The sequencing data obtained from this study will help to understand the correlation between phenotypes with mutations in resistance genes and the development of appropriate treatments and medication for the infection.

Methods

Sample collection and DNA extraction

The C. krusei clinical sample were retrieved from the Department of Parasitology Culture Collection, Faculty of Medicine, Universitas Indonesia. DNA was extracted using the QIAamp DNA Mini Kit (Qiagen, catalog number: 51304) with bead-beating methods.5 100 μL culture of C. krusei were added into 1.5 ml microcentrifuge tube containing 200 μL ATL buffer (Qiagen). Three spoon full of sterilized sand were added into the mixture for bead-beating, which was performed for 10 minutes. 20 μL Proteinase K (Qiagen) were added and the mixture was incubated at 56°C until completely lysed (three hours), and agitated every 10 minutes during incubation time, until homogeneous. 200 μL Buffer AL (Qiagen) were added and the mixture was incubated at 70°C for 10 minutes. 200 μL pure ethanol were added and the mixture was transferred into the QIAamp Mini spin column (Qiagen). Column were centrifugated at 6000 × g for one minute and the flow-through were discarded. QIAamp Mini spin columns were placed innew 2 mL collection tubes and 500 μL Buffer AW1 were added into the column. Columns were centrifugated at 6000 × g for one minute and the flow-through was discarded. QIAamp Mini spin columns were placed into new 2 mL collection tubes and 500 μL Buffer AW2 (Qiagen) were added. Columns were centrifugated at 17000 × g for three minutes and the flow-through was discarded. QIAamp Mini spin columns were transferred into new 1.5 mL microcentrifuge tubes, and 200 μl distilled water were added. Columns were incubated at room temperature for one minute and centrifugated at 6000 × g for one minute to elute the DNA. The quality of extracted DNA (A260/280) was measured using a spectrophotometer (NanoDrop ND-1000). The quantity of extracted DNA was measured with Qubit 4.0 Fluorometer using the dsDNA HS Assay kit.

Library preparation

DNA libraries were prepared using the Illumina DNA Preparation Kit. The index used for the library preparation was Integrated DNA Technologies, Inc (IDT) for Illumina Nextera Indexes for ligation step. The library construction steps were as follows:

Tagmentation

100 ng DNA were added into a 96-well plate and mixed with tagmentation master mix from Illumina Nextera Kit (Illumina). The mix were then incubated at 55°C in a thermal cycler (The Applied Biosystems ProFlex PCR System) for 15 minutes.

Post tagmentation clean-up and amplification of tagmented DNA

Illumina Nextera Kit tagment stop buffer (Illumina) were added to the tagmentation reaction and incubated at 37°C for 15 minutes. The mixture was washed with Illumina Nextera Tagment wash buffer (Illumina) on the magnetic stand. The tagment Wash Buffer was discarded and Nextera PCR master mixes (Illumina) were added onto the beads. Index adapters were added as sample barcoding. The mixture was amplified in thermal cycler.

Libraries clean-up

The beads were added into the supernatant of the mixture and washed twice using 80% ethanol on a magnetic stand. Nextera resuspension buffer (Illumina) reagents were added onto beads and final libraries were retrieved from the supernatant. The libraries of each sample were pooled.6

Whole genome sequencing

The barcoded DNA libraries were sequenced using an Illumina Miseq Platform on the v3-Flow Cell. The DNA library was denatured according to the manufacturer’s protocol.7 For quality control, the library was spiked with 1% PhiX Control v3. The sequencing run produced 2 × 301 bp paired-end libraries. The data were deposited to the NCBI Sequence Read Archive (SRA) under BioProject. Total raw reads were obtained using FastQC software, and the total raw bases and percentage of Q30 were evaluated using q30 python scripts.8

Ethical approval

This research was approved by the Faculty of Medicine Universitas Indonesia Ethical Committee (approval number: 970/UN2.F1/ETIK/PPM.00.02/2021).

Results

The whole raw genome sequence data of 16 clinical isolates of C. krusei from the Department of Parasitology, Faculty of Medicine of Universitas Indonesia were deposited into NCBI data under BioProject accession number PRJNA819536 and SRA SRR18739949-SRR18739964. The DNA quality and quantity of the samples are shown in Table 1. Information regarding the raw data is described in Table 2. These raw data of C. krusei genome are useful for genome profiling and correlating the resistant phenotypes with mutations in resistance genes.

Table 1. DNA quantity and quality.

SampleConcentration (ng/μL)Purity (A260/A280)
CK1_202113.42.1
CK2_202139.32.03
CK3_202142.32.08
CK4_202138.32.02
CK5_202134.31.95
CK6_202145.41.93
CK7_2021372.07
CK8_2021232.03
CK9_202134.32.09
CK10_202116.72.1
CK11_202118.92.05
CK12_202110.31.91
CK13_202114.21.97
CK14_202110.11.86
CK15_202117.92
CK16_20218.951.98

Table 2. Information of raw sequencing data of C. krusei clinical isolates.

SampleBioSample accession numberSRA accession numberQ30 (%)GC content (%)
CK1_2021SAMN26901813SRR1873996489.7536
CK2_2021SAMN26901814SRR1873996388.9838
CK3_2021SAMN26901815SRR1873995689.6638
CK4_2021SAMN26901816SRR1873995590.0037
CK5_2021SAMN26901817SRR1873995488.8337
CK6_2021SAMN26901818SRR1873995389.6737
CK7_2021SAMN26901819SRR1873995289.5738
CK8_2021SAMN26901820SRR1873995190.4037
CK9_2021SAMN26901821SRR1873995092.3937
CK10_2021SAMN26901822SRR1873994989.3437
CK11_2021SAMN26901823SRR1873996290.6537
CK12_2021SAMN26901824SRR1873996190.4237
CK13_2021SAMN26901825SRR1873996093.1834
CK14_2021SAMN26901826SRR1873995989.0137
CK15_2021SAMN26901827SRR1873995888.6937
CK16_2021SAMN26901828SRR1873995789.5737

Data availability

Underlying data

Raw data (FASTQ) files have been deposited into National Center for Biotechnology Information (NCBI, https://www.ncbi.nlm.nih.gov).

BioProject: Raw sequence reads of Candida krusei from clinical samples, Accession Number: PRJNA819536; https://www.ncbi.nlm.nih.gov/bioproject/PRJNA819536

BioSample: Pathogen: clinical or host-associated sample from Pichia kudriavzevii, Accession Number: SAMN26901813; https://identifiers.org/ncbiprotein:SAMN26901813

BioSample: Pathogen: clinical or host-associated sample from Pichia kudriavzevii, Accession Number: SAMN26901828; https://identifiers.org/ncbiprotein:SAMN26901828

Raw sequence reads of Candida krusei from clinical samples:

Sequence Read Archive: Raw sequence reads of Candida krusei from clinical samples, Accession Number: SRR18739949; https://identifiers.org/insdc.sra:SRR18739949

Sequence Read Archive: Raw sequence reads of Candida krusei from clinical samples, Accession Number: SRR18739964; https://identifiers.org/insdc.sra:SRR18739964

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 01 Jun 2022
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Fadilah F, Adawiyah R, Wahyuningsih R et al. Whole genome sequencing data of Candida krusei, the pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia [version 2; peer review: 2 approved]. F1000Research 2023, 11:593 (https://doi.org/10.12688/f1000research.121402.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 29 Mar 2023
Revised
Views
8
Cite
Reviewer Report 04 Jul 2023
Atanu Banerjee, Amity Institute of Biotechnology,, Amity University Haryana, Manesar, Haryana, India 
Approved
VIEWS 8
No ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Banerjee A. Reviewer Report For: Whole genome sequencing data of Candida krusei, the pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia [version 2; peer review: 2 approved]. F1000Research 2023, 11:593 (https://doi.org/10.5256/f1000research.143748.r168114)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 01 Jun 2022
Views
13
Cite
Reviewer Report 09 Jan 2023
Atanu Banerjee, Amity Institute of Biotechnology,, Amity University Haryana, Manesar, Haryana, India 
Approved with Reservations
VIEWS 13
The article by Fadilah et al, presents the whole genome sequence data of clinical isolates of C. krusei. While the genome sequence data generated could be useful to advance our knowledge regarding factors that might be responsible for the intrinsic ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Banerjee A. Reviewer Report For: Whole genome sequencing data of Candida krusei, the pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia [version 2; peer review: 2 approved]. F1000Research 2023, 11:593 (https://doi.org/10.5256/f1000research.133265.r159413)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
15
Cite
Reviewer Report 30 Aug 2022
Xuepeng Sun, Collaborative Innovation Center for Efficient and Green Production of Agriculture in Mountainous Areas of Zhejiang Province, College of Horticulture Science, Zhejiang A&F University, Hangzhou, China 
Approved
VIEWS 15
Drug resistance is a serious problem for human disease. As the human pathogen C. krusei has natural resistance to the commonly used azole fungicides, it is of particular importance to explore the molecular basis underlying the resistance. This study provides ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Sun X. Reviewer Report For: Whole genome sequencing data of Candida krusei, the pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia [version 2; peer review: 2 approved]. F1000Research 2023, 11:593 (https://doi.org/10.5256/f1000research.133265.r147383)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 01 Jun 2022
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.